Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20220115053724N1
IRCT20220115053724N1CompletedPhase 3

Evaluation of the effect of Methylprednisolone lozenge to improve symptoms of patient with oral lichen planus: An experimental study and a double-blinded randomized clinical trial

Ahvaz University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
40
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • •Age 18 to 60 years
  • •Willingness to participate in the study and complete the ethical consent form
  • •Women should not be pregnant or lactating
  • •Not using allopurinol
  • •Not using viral vaccines during treatment
  • •Patients do not have a confirmed history of allergic reactions following the oral intake of methylprednisolone
  • •The patient does not have a low level of consciousness
  • •The patient should not be treated with warfarin
  • •The patient does not have an active viral disease

Exclusion Criteria

  • •Aggravation of oral lichen lesions
  • •Unwillingness to cooperate during treatment
  • •Not using medicine for two consecutive days
  • •Emergence of allergic reaction to methylprednisolone

Investigators

Similar Trials

Completed
Phase 2
Effect of Methylprednisolone on treatment of COVID-19COVID-19 disease.COVID-19U07.2, U07
IRCT20200404046947N1Tehran University of Medical Sciences68
Completed
Not Applicable
To investigate the effect of methylprednisolone on inflammatory cytokines and urinary N-Beta-D-glucosaminidase/creatinine ratio in elective aortic aneurysm repairAbdominal aortic aneurysmAortic aneurysm
ISRCTN21626059eeds General Infirmary (UK)20
Active, not recruiting
Phase 1
To investigate the effect of methylprednisolone on inflammatory cytokines and urinary N-acetyl-beta-D-glucosaminidase/creatinine ratio in elective aortic aneurysm repair.
EUCTR2005-000195-41-GBThe Leeds Teaching Hospitals NHS Trust20
Completed
Phase 3
Methylprednisolone versus dexamethasone in patients with COVID-19COVID-19 (SARS-CoV-2 infection)Infections and Infestations
ISRCTN44151777Hospital do Rocio400
Completed
Not Applicable
Evaluation of effects of methylprednisolone injection in masseter muscle versus deltoid muscle after wisdom tooth removal
CTRI/2022/06/043230The Director70